Skip to main content

Table 2 Summary of the RCTs using co-trimoxazole in the eradication phase

From: Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review

Name

Study type

Drugs

Sample size

Open or blind

Dose

Duration of eradication phase

Relapse rate

Mortality rate

Culture positive

Clinical relapse

Chaowagul et al. [34]

RCT

1.Co-trimoxazole, doxycycline, chloramphenicol

91

Open

Co- trimoxazole (8mg TMP and 40mg SMX/kg/ daily; max 160mg TMP and 800mg SMX/twice daily

12 weeks

11.8%

 

14%

2.Co-trimoxazole (TMP/SMX), doxycycline

89

 

5.4%

 

11%

Rajchanuvong et al. [35]

 

1.Chloramphenicol, doxycycline, Co-trimoxazole

52

Open

Co-trimoxazole (10mg TMP + 50mg SMX/kg/day in 2 divided doses)

20 weeks

10%

 

1.92%

2. Doxycycline

49

36%

 

8.16%

Anunnatsiri et al. [36]

RCT

Co-trimoxazole

12 week – 322

Open

 < 40 kg, the dose used was 160/800 mg of TMP/SMX twice daily; for a body weight of 40–60 kg, the dose was 240/1200 mg of TMP/SMX twice daily; and for a body weight > 60 kg, the dose was 320/1600 mg of TMP/SMX twice daily

12 weeks

2%

 

0.3%

20 weeks

20 weeks

1%

 

3%

Chetchotisakd et al. [37]

RCT

1.Co-trimoxazole, placebo

311

Double blind

TMP-SMX (80 mg TMP and 400 mg SMX) tablets were prescribed using a weight-based dose, bodyweight less than 40 kg or eGFR 15–29 mL/min, 160 mg TMP and 800 mg SMX twice daily; bodyweight of 40 kg to 60 kg, 240 mg TMP and 1200 mg SMX twice daily; and bodyweight greater than 60 kg, 320 mg TMP and 1600 mg SMX twice daily

20 weeks

16%

3%

3%

2.Co-trimoxazole, Doxycycline

315

21%

8%

1%

Chetchotisakd et al. [4]

RCT

1. Ciprofloxacin and azithromycin

32

Open

Co- trimoxazole (10mg TMP + 50mg SMX/kg/day in 2 divided doses)

12 weeks

22%

 

3.12%

2. Co-trimoxazole and doxycycline

33

20 weeks

3%

 

0%

Chaowagal et al. [38]

RCT

1. Co-trimoxazole, doxycycline, chloramphenicol

91

Open

Co- trimoxazole (8mg TMP and 40mg SMX/kg/ daily; max 160mg TMP and 800mg SMX/twice daily

12 weeks

2%

5.9%

4.4%

 

2.Doxycycline

89

5.6%

13%

6.74%

Chaowagul et al. [34]

RCT

1.Co-trimoxazole, doxycycline, chloramphenicol

91

Open

Co- trimoxazole (8mg TMP and 40mg SMX/kg/ daily; max 160mg TMP and 800mg SMX/twice daily

12 weeks

11.8%

 

14%

2.Co-trimoxazole (TMP/SMX), doxycycline

89

 

5.4%

 

11%

Rajchanuvong et al.[35]

 

1.Chloramphenicol, doxycycline, Co-trimoxazole

52

Open

Co-trimoxazole (10mg TMP + 50mg SMX/kg/day in 2 divided doses)

20 weeks

10%

 

1.92%

2. Doxycycline

49

36%

 

8.16%

Anunnatsiri et al. [36]

RCT

Co-trimoxazole

12 week – 322

Open

 < 40 kg, the dose used was 160/800 mg of TMP/SMX twice daily; for a body weight of 40–60 kg, the dose was 240/1200 mg of TMP/SMX twice daily; and for a body weight > 60 kg, the dose was 320/1600 mg of TMP/SMX twice daily

12 weeks

2%

 

0.3%

20 weeks

20 weeks

1%

 

3%

Chetchotisakd et al. [37]

RCT

1.Co-trimoxazole, placebo

311

Double blind

TMP-SMX (80 mg TMP and 400 mg SMX) tablets were prescribed using a weight-based dose, bodyweight less than 40 kg or eGFR 15–29 mL/min, 160 mg TMP and 800 mg SMX twice daily; bodyweight of 40 kg to 60 kg, 240 mg TMP and 1200 mg SMX twice daily; and bodyweight greater than 60 kg, 320 mg TMP and 1600 mg SMX twice daily

20 weeks

16%

3%

3%

2.Co-trimoxazole, Doxycycline

315

21%

8%

1%

Chetchotisakd et al. [4]

RCT

1. Ciprofloxacin and azithromycin

32

Open

Co- trimoxazole (10mg TMP + 50mg SMX/kg/day in 2 divided doses)

12 weeks

22%

 

3.12%

2. Co-trimoxazole and doxycycline

33

20 weeks

3%

 

0%

Chaowagal et al. [38]

RCT

1. Co-trimoxazole, doxycycline, chloramphenicol

91

Open

Co- trimoxazole (8mg TMP and 40mg SMX/kg/ daily; max 160mg TMP and 800mg SMX/twice daily

12 weeks

2%

5.9%

4.4%

 

2.Doxycycline

89

5.6%

13%

6.74%